Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a … T Pillinger, RA McCutcheon, L Vano, Y Mizuno, A Arumuham, G Hindley, ... The Lancet Psychiatry 7 (1), 64-77, 2020 | 824 | 2020 |
Impaired glucose homeostasis in first-episode schizophrenia: a systematic review and meta-analysis T Pillinger, K Beck, C Gobjila, JG Donocik, S Jauhar, OD Howes JAMA psychiatry 74 (3), 261-269, 2017 | 466 | 2017 |
Defining the locus of dopaminergic dysfunction in schizophrenia: a meta-analysis and test of the mesolimbic hypothesis R McCutcheon, K Beck, S Jauhar, OD Howes Schizophrenia bulletin 44 (6), 1301-1311, 2018 | 282 | 2018 |
Treatment-resistant schizophrenia patients show elevated anterior cingulate cortex glutamate compared to treatment-responsive E Mouchlianitis, MAP Bloomfield, V Law, K Beck, S Selvaraj, N Rasquinha, ... Schizophrenia bulletin 42 (3), 744-752, 2016 | 259 | 2016 |
Synaptic loss in schizophrenia: a meta-analysis and systematic review of synaptic protein and mRNA measures EF Osimo, K Beck, T Reis Marques, OD Howes Molecular psychiatry 24 (4), 549-561, 2019 | 244 | 2019 |
Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis G Hindley, K Beck, F Borgan, CE Ginestet, R McCutcheon, D Kleinloog, ... The Lancet Psychiatry 7 (4), 344-353, 2020 | 234 | 2020 |
Association of ketamine with psychiatric symptoms and implications for its therapeutic use and for understanding schizophrenia: a systematic review and meta-analysis K Beck, G Hindley, F Borgan, C Ginestet, R McCutcheon, S Brugger, ... JAMA network open 3 (5), e204693-e204693, 2020 | 174 | 2020 |
Cholesterol and triglyceride levels in first-episode psychosis: systematic review and meta-analysis T Pillinger, K Beck, B Stubbs, OD Howes The British Journal of Psychiatry 211 (6), 339-349, 2017 | 172 | 2017 |
Presynaptic dopamine capacity in patients with treatment-resistant schizophrenia taking clozapine: an [18F] DOPA PET study E Kim, OD Howes, M Veronese, K Beck, S Seo, JW Park, JS Lee, YS Lee, ... Neuropsychopharmacology 42 (4), 941-950, 2017 | 127 | 2017 |
Antipsychotic plasma levels in the assessment of poor treatment response in schizophrenia R McCutcheon, K Beck, E D'Ambrosio, J Donocik, C Gobjila, S Jauhar, ... Acta Psychiatrica Scandinavica 137 (1), 39-46, 2018 | 110 | 2018 |
Autoantibodies to central nervous system neuronal surface antigens: psychiatric symptoms and psychopharmacological implications TA Pollak, K Beck, SR Irani, OD Howes, AS David, PK McGuire Psychopharmacology 233, 1605-1621, 2016 | 91 | 2016 |
Treatment resistant or resistant to treatment? Antipsychotic plasma levels in patients with poorly controlled psychotic symptoms R McCutcheon, K Beck, MAP Bloomfield, TR Marques, M Rogdaki, ... Journal of Psychopharmacology 29 (8), 892-897, 2015 | 68 | 2015 |
The practical management of refractory schizophrenia–the Maudsley Treatment REview and Assessment Team service approach K Beck, R McCutcheon, MAP Bloomfield, F Gaughran, T Reis Marques, ... Acta Psychiatrica Scandinavica 130 (6), 427-438, 2014 | 66 | 2014 |
Schizophrenia: from neurochemistry to circuits, symptoms and treatments OD Howes, BR Bukala, K Beck Nature Reviews Neurology 20 (1), 22-35, 2024 | 53 | 2024 |
Variability and magnitude of brain glutamate levels in schizophrenia: a meta and mega-analysis K Merritt, RA McCutcheon, A Aleman, S Ashley, K Beck, W Block, ... Molecular psychiatry 28 (5), 2039-2048, 2023 | 41 | 2023 |
Targeting glutamate to treat schizophrenia: lessons from recent clinical studies K Beck, DC Javitt, OD Howes Psychopharmacology 233 (13), 2425-2428, 2016 | 41 | 2016 |
Prevalence of treatment-resistant psychoses in the community: a naturalistic study K Beck, R McCutcheon, L Stephenson, M Schilderman, N Patel, ... Journal of Psychopharmacology 33 (10), 1248-1253, 2019 | 39 | 2019 |
The effects of cannabinoid 1 receptor compounds on memory: a meta-analysis and systematic review across species F Borgan, K Beck, E Butler, R McCutcheon, M Veronese, A Vernon, ... Psychopharmacology 236, 3257-3270, 2019 | 38 | 2019 |
Perinatal interventions for mothers and fathers who are survivors of childhood sexual abuse LA Stephenson, K Beck, P Busuulwa, C Rosan, CM Pariante, S Pawlby, ... Child Abuse & Neglect 80, 9-31, 2018 | 33 | 2018 |
Prevalence of serum N-methyl-d-aspartate receptor autoantibodies in refractory psychosis K Beck, J Lally, SS Shergill, MAP Bloomfield, JH MacCabe, F Gaughran, ... The British Journal of Psychiatry 206 (2), 164-165, 2015 | 32 | 2015 |